engleski

Leukocyte Lysosomal Enzymes in Alzheimer's Disease and Down's Syndrome

Previous studies suggested the possibility of accelerated lysosomal degradation of brain gangliosides in Alzheimer's disease (AD). As AD pathology affects both neural and non-neural tissues, the aim of this study was to determine possible changes of glycosphingolipid metabolism in available peripheral cells in Alzheimer's disease (AD) and Down's syndrome (DS). The activities of several lysosomal enzymes involved in catabolism of gangliosides and sulfatides were measured in leukocytes from subjects with dementia of the Alzheimer type (DAT), Down's syndrome and age-matched controls, by fluorimetry and spectrophotometry using specific substrates. The results showed statistically significant increase of beta-galactosidase activity in both DAT and DS leukocytes when compared with age-matched controls (P<0.01 and P<0.05, respectively, Student t-test). Not significantly increased activities of beta-galactosidase, beta-hexosaminidase, beta-hexosaminidase A, and slightly decreased activity of arylsulfatase A were observed in control leukocytes with aging. Our results indicate that a metabolic dysfunction and the acceleration of at least some lysosomal catabolic pathways are present in AD and DS non-neural cells.

lysosomal enzymes; Alzheimer's disease; Down's syndrome; aging

nije evidentirano